PMID- 23696861 OWN - NLM STAT- MEDLINE DCOM- 20131223 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 5 DP - 2013 TI - Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia. PG - e63951 LID - 10.1371/journal.pone.0063951 [doi] LID - e63951 AB - Hyperhomocysteinemia (HHcy) is a risk factor for cognitive impairment. The purpose of this study was to determine the temporal pattern of cerebral pathology in a mouse model of mild HHcy, because understanding this time course provides the basis for understanding the mechanisms involved. C57Bl/6 mice with heterozygous deletion cystathionine beta-synthase (cbs (+/-); Het) were used as a model of mild HHcy along with their wild-type littermates (cbs (+/+); WT). Mice were 'young' (5.3+/-0.2 months of age) and 'old' (16.6+/-0.9 months of age). Blood-brain barrier (BBB) permeability was quantified from Evans blue and sodium fluorescein extravasation. Microvascular architecture was assessed by z-stack confocal microscopy. Leukoaraiosis was measured from Luxol fast blue stained slides of paraffin brain sections. Inflammation was quantified using standard antibody-based immunohistochemical techniques. Cognitive function was assessed using the Morris water maze. BBB permeability was significantly greater in Het vs. WT mice at all ages (p<0.05). There were no differences in microvascular architecture among the groups. Compared with all other groups, old Het mice had significantly greater leukoaraiosis, inflammation in the fornix, and cognitive impairment (p<0.05). In mild HHcy, increased permeability of the BBB precedes the onset of cerebral pathology. This new paradigm may play a role in the progression of disease in HHcy. FAU - Rhodehouse, Bryce C AU - Rhodehouse BC AD - Department of Biological Sciences, Idaho State University, Pocatello, Idaho, United States of America. FAU - Mayo, Jamie N AU - Mayo JN FAU - Beard, Richard S Jr AU - Beard RS Jr FAU - Chen, Cheng-Hung AU - Chen CH FAU - Bearden, Shawn E AU - Bearden SE LA - eng GR - P20 RR016454/RR/NCRR NIH HHS/United States GR - R15 HL106548/HL/NHLBI NIH HHS/United States GR - P20 RR-016454/RR/NCRR NIH HHS/United States GR - HL106548/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130516 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 45PG892GO1 (Evans Blue) RN - EC 4.2.1.22 (Cystathionine beta-Synthase) SB - IM MH - Animals MH - Blood-Brain Barrier/*pathology/physiopathology MH - Brain/*pathology/physiopathology MH - Cystathionine beta-Synthase/genetics/metabolism MH - Disease Models, Animal MH - Evans Blue/chemistry MH - Hyperhomocysteinemia/pathology/*physiopathology MH - Leukoaraiosis/pathology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Microscopy, Confocal PMC - PMC3655957 COIS- Competing Interests: Author Shawn Bearden is an Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. EDAT- 2013/05/23 06:00 MHDA- 2013/12/24 06:00 PMCR- 2013/05/16 CRDT- 2013/05/23 06:00 PHST- 2013/01/13 00:00 [received] PHST- 2013/04/08 00:00 [accepted] PHST- 2013/05/23 06:00 [entrez] PHST- 2013/05/23 06:00 [pubmed] PHST- 2013/12/24 06:00 [medline] PHST- 2013/05/16 00:00 [pmc-release] AID - PONE-D-13-02008 [pii] AID - 10.1371/journal.pone.0063951 [doi] PST - epublish SO - PLoS One. 2013 May 16;8(5):e63951. doi: 10.1371/journal.pone.0063951. Print 2013.